Session I: New Developments and Technologies in Biomarker Discovery Nano-Technology in Medicine / Nano-Markers  ‘Omics screening  Tissue Mircoarray  Whole Blood Screening (Minimal Sample Prep) Mutli-Analyte Testing / Assay Session II: Overcoming the Discovery to Validation Bottleneck Strategies and Methodologies (Case Studies) Regulatory Perspective / Requirements (EMEA) Commercial Impact / Cost Structures Session III: Approach to Formulation & Drug Delivery of Biomarkers Companion Diagnostics Theranostics Multi-Target Biomarkers / Multi-Biomarker Panels Bio-Sensors – In Vitro Assays to Detect Particular Marker / Biochemical Molecules Biomarkers Inside of Single Cells Session IV: Biomarkers in Oncology Oncogenes Circulating Tumor Cells DNA Methylation Session V: Biomarkers in Translational Research Evidence Based Approach Diagnostic Biomarkers Safety Markers PK/PD/TD Biomarkers Session VI: Biomarkers in Clinical Development Imaging Biomarkers – Irradiated Antibodies, PET, OTC, MRI Imaging Focus on the Utility of Biomarkers Patient Stratification